Improving outcomes for infants with hydrocephalus in Uganda
Improving infant hydrocephalus outcomes in Uganda: Predicting developmental outcomes and identifying patients at risk for early treatment failure after ETV/CPC
This study is looking at a new way to help babies in Uganda with hydrocephalus, especially those who got it after an infection, by using a special treatment that might reduce the need for shunts, which can be tricky to manage; the goal is to see how this treatment helps their brain growth and development.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10428554 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment outcomes for infants suffering from hydrocephalus in Uganda, particularly those affected by post-infectious hydrocephalus. The study evaluates a novel treatment approach that combines endoscopic third ventriculostomy with choroid plexus cauterization (ETV/CPC), aiming to reduce the dependency on shunts, which often fail and require ongoing maintenance. By analyzing brain growth as a key indicator of developmental outcomes, the research seeks to identify patients at risk for treatment failure and improve early intervention strategies. The methodology includes monitoring brain growth and developmental progress in infants receiving this innovative treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants diagnosed with post-infectious hydrocephalus in sub-Saharan Africa.
Not a fit: Patients who do not have hydrocephalus or are outside the targeted geographic region may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved developmental outcomes and a better quality of life for infants with hydrocephalus in low-resource settings.
How similar studies have performed: Previous research has shown promising results with the ETV/CPC approach, indicating potential for significant improvements in treatment outcomes compared to traditional methods.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Lin, Pei-Yi — Boston Children's Hospital
- Study coordinator: Lin, Pei-Yi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.